Oncolytics Biotech Investor Relations Material
Latest events
AGM 2025
Oncolytics Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oncolytics Biotech Inc
Access all reports
Oncolytics Biotech Inc is a biotechnology company developing immuno-oncology therapies to treat various cancers. The company focuses on the development of proprietary viral-based therapies that stimulate the immune system to target and destroy cancer cells. Oncolytics Biotech conducts clinical research and collaborates with pharmaceutical and academic partners. The company is headquartered in Calgary, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
ONCY
Country
🇺🇸 United States